Symptom burden: a forgotten area of measurement in inflammatory bowel disease
- PMID: 23009379
- DOI: 10.1111/j.1440-172X.2012.02063.x
Symptom burden: a forgotten area of measurement in inflammatory bowel disease
Abstract
Inflammatory bowel disease (IBD) collectively known as Crohn's disease and ulcerative colitis are chronic inflammatory diseases of the digestive tract. Periods of active and inactive disease are common along the trajectory of this illness. A range of symptoms such as fatigue, diarrhoea and abdominal pain are experienced and are often very debilitating in nature resulting in significance interference in daily life. Despite this, to date, research in the area of symptoms remains an underexplored topic. This paper aims to discuss current approaches to symptom assessment in IBD and the potential to measure symptom burden in further research, in order to gain a greater understanding into the experiences of individuals with IBD.
© 2012 Wiley Publishing Asia Pty Ltd.
Similar articles
-
The Short Inflammatory Bowel Disease Questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT Investigators. Canadian Crohn's Relapse Prevention Trial.Am J Gastroenterol. 1996 Aug;91(8):1571-8. Am J Gastroenterol. 1996. PMID: 8759664 Clinical Trial.
-
The Manitoba Inflammatory Bowel Disease Cohort Study: prolonged symptoms before diagnosis--how much is irritable bowel syndrome?Clin Gastroenterol Hepatol. 2006 May;4(5):614-20. doi: 10.1016/j.cgh.2006.03.003. Epub 2006 Apr 17. Clin Gastroenterol Hepatol. 2006. PMID: 16630762
-
Identification of a prodromal period in Crohn's disease but not ulcerative colitis.Am J Gastroenterol. 2000 Dec;95(12):3458-62. doi: 10.1111/j.1572-0241.2000.03361.x. Am J Gastroenterol. 2000. PMID: 11151877
-
[Circumstances of the diagnosis and clinical course of inflammatory bowel disease].Rev Prat. 2005 May 15;55(9):962-76. Rev Prat. 2005. PMID: 16052967 Review. French.
-
Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.Dig Liver Dis. 2005 Jun;37(6):407-17. doi: 10.1016/j.dld.2004.12.013. Dig Liver Dis. 2005. PMID: 15893279 Review.
Cited by
-
"I can fight it!": A qualitative study of resilience in people with inflammatory bowel disease.Int J Nurs Sci. 2018 Dec 26;6(2):127-133. doi: 10.1016/j.ijnss.2018.12.008. eCollection 2019 Apr 10. Int J Nurs Sci. 2018. PMID: 31406881 Free PMC article.
-
Self-Care Among Patients With Inflammatory Bowel Disease: An Interview Study.Gastroenterol Nurs. 2016 Mar-Apr;39(2):121-8. doi: 10.1097/SGA.0000000000000120. Gastroenterol Nurs. 2016. PMID: 26166423 Free PMC article.
-
Neuroprotective Potential of Mesenchymal Stem Cell-Based Therapy in Acute Stages of TNBS-Induced Colitis in Guinea-Pigs.PLoS One. 2015 Sep 23;10(9):e0139023. doi: 10.1371/journal.pone.0139023. eCollection 2015. PLoS One. 2015. PMID: 26397368 Free PMC article.
-
The actuality of resilience, social support and quality of life among patients with inflammatory bowel disease in China.Nurs Open. 2022 Jul;9(4):2190-2198. doi: 10.1002/nop2.946. Epub 2021 May 26. Nurs Open. 2022. PMID: 34037332 Free PMC article.
-
Self-reported Symptom Burden in Individuals with Inflammatory Bowel Disease.J Crohns Colitis. 2016 Mar;10(3):315-22. doi: 10.1093/ecco-jcc/jjv218. Epub 2015 Nov 22. J Crohns Colitis. 2016. PMID: 26598526 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources